Endovia Health Sciences (EDVA) Shares Outstanding (Diluted) (2018 - 2026)
Analysis
Endovia Health Sciences (EDVA) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.44 Bn | 133.58 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.65 Bn | 78.66 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 65.10 Bn | 59.92 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.10 Bn | 51.97 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.13 Bn | 27.30 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 3.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.06 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 544,599.00 |
| Sep 30, 2025 | 547,883.00 |
| Jun 30, 2025 | 474,969.00 |
| Mar 31, 2025 | 464,303.00 |
| Dec 31, 2024 | 334,607.00 |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 12.28 Mn |
| Mar 31, 2024 | 11.20 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | 10.70 Mn |
| Jun 30, 2023 | 10.51 Mn |
| Mar 31, 2023 | 9.35 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 9.72 Mn |
| Jun 30, 2022 | 9.17 Mn |
| Mar 31, 2022 | 7.23 Mn |
| Dec 31, 2021 | 7.23 Mn |
| Sep 30, 2021 | 7.63 Mn |